本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEWAMSTERDAM PHARMA CO NV

22.80
+0.94004.30%
盤後22.800.00000.00%19:30 EDT
成交量:159.65萬
成交額:3,581.02萬
市值:27.25億
市盈率:-10.63
高:23.00
開:22.11
低:21.23
收:21.86
52周最高:42.21
52周最低:21.23
股本:1.20億
流通股本:9,251.29萬
量比:0.79
換手率:1.73%
股息:- -
股息率:- -
每股收益(TTM):-2.1442
每股收益(LYR):-1.7211
淨資產收益率:-36.81%
總資產收益率:-20.11%
市淨率:4.32
市盈率(LYR):-13.25

資料載入中...

2026/08/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/07/24

重要事件披露

Form 8-K - Current report
2026/07/22

重要事件披露

Form 8-K - Current report
2026/06/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/04

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/24

重要事件披露

Form 8-K - Current report
2026/03/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities